Delays in cancer registry reporting may have skewed the findings of the NordICC trial, which evaluated the long-term impact of screening colonoscopies. The trial, involving over 85,000 adults, excluded 221 participants with pre-existing colorectal cancer (CRC) that hadn’t yet appeared in registries—raising questions about the accuracy of reported outcomes. Researchers estimate that 2-3 year delays may have masked the true effectiveness of colonoscopies, showing a lower impact on CRC prevention than reality. If registration had been timely, risk reductions and outcomes could have been significantly better, suggesting a need for deeper investigation. What else might this delay reveal about the real power of colonoscopies?
Trending
- 7 HLTH Announcements You Don’t Want to Miss (MedCity News)
- Practical Tips for Contracting, Part 2 (GI & Endoscopy News)
- GRAIL PATHFINDER 2 Results Show Galleri® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings (GRAIL)
- Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates (AJMC)
- St. Charles Health System Taps WovenX to Transform GI Access and Optimize Capacity (PR Newswire)
- United Digestive adds 5 gastroenterologists in 3 months (Becker’s GI & Endoscopy)
- Negotiated Prices for Large Insurers and Regional Differences in Employed Cardiology and GI Groups Revealed (Medscape)
- Health care in the USA: money has become the mission (The Lancet)
